4//SEC Filing
BOLNO PAUL 4
Accession 0000950170-24-131691
CIK 0001631574other
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 9:00 PM ET
Size
8.5 KB
Accession
0000950170-24-131691
Insider Transaction Report
Form 4
BOLNO PAUL
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Ordinary Shares
2024-11-25$2.48/sh+50,000$124,000→ 267,351 total - Exercise/Conversion
Share Option (right to buy)
2024-11-25−50,000→ 47,778 totalExercise: $2.48Exp: 2025-03-10→ Ordinary Shares (50,000 underlying) - Sale
Ordinary Shares
2024-11-25$15.00/sh−50,000$750,000→ 217,351 total
Footnotes (2)
- [F1]The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024.
- [F2]These share options are fully vested.
Documents
Issuer
Wave Life Sciences Ltd.
CIK 0001631574
Entity typeother
Related Parties
1- filerCIK 0001657710
Filing Metadata
- Form type
- 4
- Filed
- Nov 26, 7:00 PM ET
- Accepted
- Nov 27, 9:00 PM ET
- Size
- 8.5 KB